Pharmacy Question for the Week of July 10, 2017

Pharmacy Compliance Question of the Week


I was reviewing the archive and came across a Q&A related to modifier JW. That answer states that the modifier relates only to single-use vials—a vial of liquid medication intended for parenteral administration (injection or infusion) that is meant for use in a single patient for a single case, procedure or injection. This would seem to mean that the modifier would not apply to packages for non-liquid drugs. Is that correct?


The JW modifier applies to single-dose vials, but it also applies to single-use packages for drugs and biologicals that would not be dispensed in liquid form. This is for something such as skin substitutes or other single-use products that are applied or implanted and not infused.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.